{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T05:13:21Z","timestamp":1783660401788,"version":"3.55.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CNS Drugs"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s40263-026-01309-5","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T14:55:52Z","timestamp":1781621752000},"page":"1029-1036","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Managing Dermatologic Delusional Disorders: A US Psychodermatology Perspective for Clinicians"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-6165-3071","authenticated-orcid":false,"given":"Andrea","family":"Leung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-1005-5221","authenticated-orcid":false,"given":"John","family":"Koo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,16]]},"reference":[{"issue":"5","key":"1309_CR1","doi-asserted-by":"publisher","first-page":"285","DOI":"10.2165\/00128071-200102050-00003","volume":"2","author":"J Koo","year":"2001","unstructured":"Koo J, Lee CS. Delusions of parasitosis. A dermatologist\u2019s guide to diagnosis and treatment. Am J Clin Dermatol. 2001;2(5):285\u201390. https:\/\/doi.org\/10.2165\/00128071-200102050-00003.","journal-title":"Am J Clin Dermatol"},{"issue":"4","key":"1309_CR2","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1128\/CMR.00018-09","volume":"22","author":"RW Freudenmann","year":"2009","unstructured":"Freudenmann RW, Lepping P. Delusional infestation. Clin Microbiol Rev. 2009;22(4):690\u2013732. https:\/\/doi.org\/10.1128\/CMR.00018-09.","journal-title":"Clin Microbiol Rev"},{"issue":"4","key":"1309_CR3","doi-asserted-by":"publisher","first-page":"337","DOI":"10.7861\/clinmedicine.15-4-337","volume":"15","author":"P Lepping","year":"2015","unstructured":"Lepping P, Stanly T, Turner J. Systematic review on the prevalence of lack of capacity in medical and psychiatric settings. Clin Med (Lond). 2015;15(4):337\u201343. https:\/\/doi.org\/10.7861\/clinmedicine.15-4-337.","journal-title":"Clin Med (Lond)"},{"issue":"4","key":"1309_CR4","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1111\/bjd.21668","volume":"187","author":"A Ahmed","year":"2022","unstructured":"Ahmed A, Affleck AG, Angus J, Assalman I, Baron SE, Bewley A, et al. British Association of Dermatologists guidelines for the management of adults with delusional infestation 2022. Br J Dermatol. 2022;187(4):472\u201380. https:\/\/doi.org\/10.1111\/bjd.21668.","journal-title":"Br J Dermatol"},{"issue":"12","key":"1309_CR5","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1093\/trstmh\/trae054","volume":"118","author":"SB Squire","year":"2024","unstructured":"Squire SB, Taegtmeyer M, Javed Q, O\u2019Dempsey T, Kullu C, Lepping P. A combined tropical medicine and psychiatry approach to patients with possible delusional infestation. Trans R Soc Trop Med Hyg. 2024;118(12):808\u201313. https:\/\/doi.org\/10.1093\/trstmh\/trae054.","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"12","key":"1309_CR6","doi-asserted-by":"publisher","first-page":"2993","DOI":"10.1007\/s13555-023-01053-4","volume":"13","author":"S Coetzee","year":"2023","unstructured":"Coetzee S, Mahajan C, Fran\u00e7a K. The diagnostic workup, screening, and treatment approaches for patients with delusional infestation. Dermatol Ther (Heidelb). 2023;13(12):2993\u20133006. https:\/\/doi.org\/10.1007\/s13555-023-01053-4.","journal-title":"Dermatol Ther (Heidelb)."},{"issue":"7","key":"1309_CR7","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1111\/ijd.12067","volume":"52","author":"MM Heller","year":"2013","unstructured":"Heller MM, Wong JW, Lee ES, Ladizinski B, Grau M, Howard JL, et al. Delusional infestations: clinical presentation, diagnosis and treatment. Int J Dermatol. 2013;52(7):775\u201383. https:\/\/doi.org\/10.1111\/ijd.12067.","journal-title":"Int J Dermatol"},{"issue":"8","key":"1309_CR8","doi-asserted-by":"publisher","first-page":"3199","DOI":"10.1080\/09546634.2022.2112548","volume":"33","author":"N Brownstone","year":"2022","unstructured":"Brownstone N, Koo J. The Koo-Brownstone staging system as a tool to assist in the management of patients with a possible diagnosis of dermatological delusions: an experts suggestion. J Dermatol Treat. 2022;33(8):3199\u2013201. https:\/\/doi.org\/10.1080\/09546634.2022.2112548.","journal-title":"J Dermatol Treat"},{"key":"1309_CR9","doi-asserted-by":"publisher","unstructured":"Chakrabarty AC, Bennett JI, Baloch TJ, Shah RP, Hawk C, Natof T. Increasing Abnormal Involuntary Movement Scale (AIMS) screening for tardive dyskinesia in an outpatient psychiatry clinic: a resident-led outpatient lean six sigma initiative. Cureus. 15(5):e39486. https:\/\/doi.org\/10.7759\/cureus.39486.","DOI":"10.7759\/cureus.39486"},{"key":"1309_CR10","unstructured":"Christian R, Saavedra L, Gaynes BN, Sheitman B, Wines RC, Jonas DE, et al. Tables of FDA-approved indications for first- and second-generation antipsychotics. In: Future research needs for first- and second-generation antipsychotics for children and young adults [Internet] [Internet]. Agency for Healthcare Research and Quality (US); 2012 [cited 2026 May 19]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK84656\/."},{"issue":"6","key":"1309_CR11","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1046\/j.1365-2133.1998.02272.x","volume":"138","author":"SF Zomer","year":"1998","unstructured":"Zomer SF, De Wit RF, Van Bronswijk JE, Nabarro G, Van Vloten WA. Delusions of parasitosis. A psychiatric disorder to be treated by dermatologists? An analysis of 33 patients. Br J Dermatol. 1998;138(6):1030\u20132. https:\/\/doi.org\/10.1046\/j.1365-2133.1998.02272.x.","journal-title":"Br J Dermatol"},{"issue":"1","key":"1309_CR12","doi-asserted-by":"publisher","first-page":"55","DOI":"10.2340\/00015555625558","volume":"62","author":"K Hamann","year":"1982","unstructured":"Hamann K, Avnstorp C. Delusions of infestation treated by pimozide: a double-blind crossover clinical study. Acta Derm Venereol. 1982;62(1):55\u20138.","journal-title":"Acta Derm Venereol"},{"issue":"4","key":"1309_CR13","doi-asserted-by":"publisher","first-page":"959","DOI":"10.3390\/clinpract13040087","volume":"13","author":"JP Rissardo","year":"2023","unstructured":"Rissardo JP, Vora N, Mathew B, Kashyap V, Muhammad S, Fornari Caprara AL. Overview of movement disorders secondary to drugs. Clin Pract. 2023;13(4):959\u201376. https:\/\/doi.org\/10.3390\/clinpract13040087.","journal-title":"Clin Pract"},{"issue":"12","key":"1309_CR14","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1056\/NEJMra2404606","volume":"391","author":"EFM Wijdicks","year":"2024","unstructured":"Wijdicks EFM, Ropper AH. Neuroleptic malignant syndrome. N Engl J Med. 2024;391(12):1130\u20138. https:\/\/doi.org\/10.1056\/NEJMra2404606.","journal-title":"N Engl J Med"},{"issue":"45","key":"1309_CR15","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jdcr.2024.01.010","volume":"20","author":"RA Gutierrez","year":"2024","unstructured":"Gutierrez RA, Smith P, Kranyak A, Davis M, Koo J. Pimozide-induced tardive dyskinesia in the treatment of delusions of infestation. JAAD Case Rep. 2024;20(45):71\u20133. https:\/\/doi.org\/10.1016\/j.jdcr.2024.01.010.","journal-title":"JAAD Case Rep."},{"issue":"5","key":"1309_CR16","doi-asserted-by":"publisher","first-page":"339","DOI":"10.2165\/00128071-200405050-00007","volume":"5","author":"CR Lorenzo","year":"2004","unstructured":"Lorenzo CR, Koo J. Pimozide in dermatologic practice: a comprehensive review. Am J Clin Dermatol. 2004;5(5):339\u201349. https:\/\/doi.org\/10.2165\/00128071-200405050-00007.","journal-title":"Am J Clin Dermatol"},{"issue":"14","key":"1309_CR17","doi-asserted-by":"publisher","first-page":"1237446","DOI":"10.3389\/fphar.2023.1237446","volume":"10","author":"F Facal","year":"2023","unstructured":"Facal F, Portela B, Gil-Rodr\u00edguez A, Barros F, Maro\u00f1as O, Carracedo A. Deletion of the CYP2D6 gene as a likely explanation for the serious side effects of the antipsychotic drug pimozide: a case report. Front Pharmacol. 2023;10(14):1237446. https:\/\/doi.org\/10.3389\/fphar.2023.1237446.","journal-title":"Front Pharmacol"},{"issue":"2","key":"1309_CR18","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1080\/09546634.2020.1795061","volume":"33","author":"ML McPhie","year":"2022","unstructured":"McPhie ML, Kirchhof MG. A systematic review of antipsychotic agents for primary delusional infestation. J Dermatol Treat. 2022;33(2):709\u201321. https:\/\/doi.org\/10.1080\/09546634.2020.1795061.","journal-title":"J Dermatol Treat"},{"issue":"4","key":"1309_CR19","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1093\/ced\/llad411","volume":"49","author":"NLKO Guedes","year":"2024","unstructured":"Guedes NLKO, Dwan AJ, Gerlero P, Nico MMS. Delusional infestation treated with risperidone: a series of 27 patients. Clin Exp Dermatol. 2024;49(4):364\u20137. https:\/\/doi.org\/10.1093\/ced\/llad411.","journal-title":"Clin Exp Dermatol"},{"key":"1309_CR20","unstructured":"DailyMed - RISPERIDONE tablet RISPERIDONE solution RISPERIDONE M-TAB- risperidone tablet, orally disintegrating [Internet]. [cited 2026 Jan 24]. Available from: https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=701e1cd8-2868-4d29-85a9-a2212c88165f."},{"key":"1309_CR21","unstructured":"Dean L. Risperidone Therapy and CYP2D6 Genotype. In: Pratt VM, Scott SA, Pirmohamed M, Esquivel B, Kattman BL, Malheiro AJ, editors. Medical Genetics Summaries [Internet]. Bethesda: National Center for Biotechnology Information (US); 2012 [cited 2026 Jan 24]. Available from: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK425795\/."},{"issue":"5","key":"1309_CR22","doi-asserted-by":"publisher","first-page":"285","DOI":"10.2165\/00128071-200102050-00003","volume":"2","author":"J Koo","year":"2001","unstructured":"Koo J, Lee CS. Delusions of parasitosis. Am J Clin Dermatol. 2001;2(5):285\u201390. https:\/\/doi.org\/10.2165\/00128071-200102050-00003.","journal-title":"Am J Clin Dermatol"},{"key":"1309_CR23","first-page":"101","volume-title":"Morgellons disease: high yield principles for clinical practice","author":"DND Brownstone","year":"2020","unstructured":"Brownstone DND, Beck DK, Sekhon DS, Koo DJ. Morgellons disease: high yield principles for clinical practice. Monee: Independently published; 2020. p. 101."},{"issue":"6","key":"1309_CR24","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1111\/ggi.13669","volume":"19","author":"AM Thomson","year":"2019","unstructured":"Thomson AM, Wallace J, Kobylecki C. Tardive dyskinesia after drug withdrawal in two older adults: clinical features, complications and management. Geriatr Gerontol Int. 2019;19(6):563\u20134. https:\/\/doi.org\/10.1111\/ggi.13669.","journal-title":"Geriatr Gerontol Int"}],"container-title":["CNS Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-026-01309-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40263-026-01309-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-026-01309-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T04:18:29Z","timestamp":1783657109000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40263-026-01309-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,16]]},"references-count":24,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["1309"],"URL":"https:\/\/doi.org\/10.1007\/s40263-026-01309-5","relation":{},"ISSN":["1172-7047","1179-1934"],"issn-type":[{"value":"1172-7047","type":"print"},{"value":"1179-1934","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,16]]},"assertion":[{"value":"26 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr.\u00a0Andrea Leung has no disclosures. Dr. John Koo is a consultant for Regeneron-Sanofi, Castle, Pfizer, Arcutis, and Celltrion. He is also a speaker of Abbvie, Regeneron-Sanofi, Pfizer, SUN, Leo, Dermavant, Eli Lilly, Bristol-Meyer-Squibb, Galderma, UCB, and Pfizer. However, because the topic of this article is psychodermatology and not psoriasis or eczema, none of these companies are relevant for the research, authorship, and\/or publication of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and materials"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"AL contributed to conceptual development, literature review, manuscript preparation, and manuscript revision. JK contributed to conceptual development, manuscript preparation, manuscript revision, and project supervision. Both authors read and approved the final version.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}}]}}